Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Shares Issued (2019 - 2025)

Eton Pharmaceuticals (ETON) has disclosed Shares Issued for 7 consecutive years, with -$394000.0 as the latest value for Q4 2025.

  • Quarterly Shares Issued fell 138.82% to -$394000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 million through Sep 2025, up 1104.27% year-over-year, with the annual reading at $1.2 million for FY2024, 420.09% up from the prior year.
  • Shares Issued hit -$394000.0 in Q4 2025 for Eton Pharmaceuticals, down from $394000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $1.0 million in Q4 2024 to a low of -$394000.0 in Q4 2025.
  • Historically, Shares Issued has averaged $124750.0 across 5 years, with a median of $85500.0 in 2021.
  • Biggest five-year swings in Shares Issued: crashed 272.06% in 2022 and later surged 5528.57% in 2025.
  • Year by year, Shares Issued stood at $68000.0 in 2021, then plummeted by 272.06% to -$117000.0 in 2022, then soared by 49.57% to -$59000.0 in 2023, then surged by 1820.34% to $1.0 million in 2024, then tumbled by 138.82% to -$394000.0 in 2025.
  • Business Quant data shows Shares Issued for ETON at -$394000.0 in Q4 2025, $394000.0 in Q1 2025, and $1.0 million in Q4 2024.